PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Cash Flow (Statement)
-$59.42M
TTM · Period ending: · USD
PHAS Operating Cash Flow (Statement)
Latest reported-$59.42Mperiod ending
Latest reported-$59.42Mperiod ending
PHAS Cash from Operations (-$9.69M → -$59.42M)
Annual operating cash flow (statement)
High-resolution chart · PNG
PHAS operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -47,416,000 | |
| -59,957,000 | |
| -39,594,000 | |
| -17,053,000 | |
| -8,259,000 | |
| -9,688,000 |